AzTrials
AzTrials

DepressionBBQSNCT06648460

Multimodal Differences in Effort-based Decision-Making in Depression

A study testing Effort-based Decision-Making Task in people with Depression and Anhedonia, run by Georgia Institute of Technology at 1 site in United States.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Major depressive disorder (MDD) is a serious condition that causes long-term symptoms such as feeling sad, losing interest in activities, and having thoughts of self-harm. Difficulty in making an effort is a key factor in functional impairment. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Depression, Anhedonia
What is being tested?
Effort-based Decision-Making Task
Could I receive a placebo?
No, everyone receives an active treatment
How many people
90 participants
Where
1 siteUnited States
Study dates
1 Jan 2027to 30 Sep 2030
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Matched control group
  • 18-65 years old
  • Able-bodied
  • Fluent in English
  • Able to give written and verbal informed consent to the proposed experiment
  • Able to comprehend the study procedure, potential risks, and benefits
Show all 14Show fewer
  • Group with depression
  • Diagnosed with major depression
  • Quick Inventory of Depression Symptomology (QIDS) score > 5
  • 18-65 years old
  • Able-bodied
  • Fluent in English
  • Able to give written and verbal informed consent to the proposed experiment
  • Able to comprehend the study procedure, potential risks, and benefits

Who cannot join

  • Matched control group
  • Current diagnosed psychiatric disorder (e.g., anxiety, depression, bipolar disorder)
  • Current pregnancy
  • BMI > 35
  • Currently on antipsychotics
  • Group with depression
Show all 11Show fewer
  • Diagnosed with psychotic symptoms
  • Diagnosed with other neurological or psychiatric disorders
  • Current pregnancy
  • BMI > 35
  • Currently on antipsychotics

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Christopher J Rozell, Ph.D. contact

404-385-7671

crozell@gatech.edu

Sankaraleengam Alagapan, Ph.D. contact

sankar.alagapan@gatech.edu

United States1 site
  • Georgia Tech Manufacturing Institute

    Atlanta, Georgia, 30308

    Christopher J Rozell, Ph.D., 404-385-7671, crozell@gatech.edu

    Sankaraleengam Alagapan, Ph.D., sankar.alagapan@gatech.edu

Other trials in United States

About this study

Official title: Multimodal Differences in Effort-based Decision-Making in Depression - - Brain Behavior Quantification and Synchronization

Major depressive disorder (MDD) is a serious condition that causes long-term symptoms such as feeling sad, losing interest in activities, and having thoughts of self-harm. Difficulty in making an effort is a key factor in functional impairment. Current methods to evaluate this difficulty use clinical assessments and computer-based tasks, but there is a gap between the measurements and real-life behavior. To address this, the study team proposes creating an instrumented behavioral test, HORMES, to objectively assess reduced motivation during everyday activities and measure physiological responses. The study will examine differences in brain activity, autonomic system function, and metabolic energy expenditure in patients with major depression during a decision-making task that involves physical effort.

Read the detailed description

Major depressive disorder (MDD) is a debilitating neuropsychiatric condition characterized by multiple chronic symptoms, including sad mood, anhedonia, psychomotor symptoms, and suicidal thoughts. MDD induces significant personal and societal suffering, becoming the largest contributor to the overall disease burden in developed countries. There is clearly an urgent need to advance our understanding of MDD and its constituent symptoms. Of these, the inability to expend effort have proven harder to treat than mood-related symptoms and are key predictors of functional impairment and disease burden. The biological mechanisms that contribute to this impairment are not fully understood. Addressing this gap in knowledge will be helpful in developing therapy, including novel brain stimulation therapies that offer the ability to target brain circuits precisely.

Current evaluation approaches to characterizing reduced motivation rely on clinical assessments of patient symptoms through interviews and observation. While these typically assess functions relevant to patient quality of life, these assessments may be confounded by biases. On the other hand, translational research focuses on characterizing symptoms using computer-based tasks that provide quantitative objective markers (e.g., reaction time in pressing a key on a keyboard) but may not reflect real-life situations. In addition, studies investigating brain mechanisms often use functional magnetic resonance imaging (fMRI), which requires patients to be stationary. Thus, there is a fundamental disconnect between measurements of behavior and the behavior itself under study.

To overcome these limitations, the study team envisions developing an instrumented behavioral assay, HORMES, that allows the objective assessment of reduced motivation during naturalistic behavior with concurrent measurements of the central and autonomic nervous systems as well as metabolic energy expenditure. This assay will utilize a CAREN system at Human Augmentation Core, a core facility available at Georgia Tech that is currently used for biomechanics research.

The proposed study will investigate differences in brain activity, autonomic system function, and metabolic energy expenditure in patients with major depression and matched controls during an effort-based decision-making task. The study team will collect multiple physiological measures - brain activity, cardiac activity, breathing activity, and energy expenditure in patients with major depression when they walk on a treadmill. Biomechanical information will be obtained using motion capture. The amount of effort they will need to expend will be varied by adjusting the treadmill's incline. These measures will be compared against those from a control group with age, gender, and BMI-matched healthy individuals.

The outcome of this study will inform what differences exist between healthy individuals and individuals with depression. The participants will be recruited from the Atlanta metro area and will all be allocated to the intervention. which is a behavioral task. The task requires participants to maximize rewards by choosing to pursue actions of different levels of physical effort (walking).

Being tested
Effort-based Decision-Making Task
Keywords
Effort-based decision-making, Physical Effort
Medical subject headings
Depression, Anhedonia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Effort-based Decision-Making TaskOther

    Virtual Reality-based multi-stage task in which individuals must explore distinct "rooms" in a virtual environment that vary in the amount of effort (walking) and reward (points) they receive.

Study groups in NCT06648460
Study groupRoleWhat they receive
Effort-based decision-makingOtherParticipants perform a virtual-reality-based task in which they expend effort to receive virtual rewards.
Receives: Other: Effort-based Decision-Making Task

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time spent in high-effort "rooms"

    Participants will be measured on how much time they spend in "rooms" that require high effort in the form of walking on an inclined treadmill as a proportion of the total duration of the task. This measures the willingness of participants to engage in effortful behavior.

    Measured: 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Oct 2024
  2. Study start1 Jan 2027 (estimated)
  3. Primary completion31 Aug 2029 (estimated)
  4. Study completion30 Sep 2030 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Model description
This is a single group study in which individuals with depression and matched controls will perform an effort-based decision-making task.
Masking
None (open label)
Enrolment
90 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06648460
Sponsor's protocol ID
H24306
Acronym
BBQS
Status last verified
Aug 2026
First submitted
17 Oct 2024
Last updated
27 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: De-identified data will be shared in the NIMH Data Archive (NDA) at the end of the project. De-identified data sets will be anonymized prior to posting on the public repository. Shared data will include behavioral task outcomes, physiological data, and participant demographics.

Questions about this trial

What is this clinical trial studying?

A study testing Effort-based Decision-Making Task in people with Depression and Anhedonia, run by Georgia Institute of Technology at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 14 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 27 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Christopher J Rozell, Ph.D. (404-385-7671, crozell@gatech.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time spent in high-effort "rooms" (time frame: 1 day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Aug 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in